WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 559062

CAS#: 73278-54-3

Description: Lamtidine is a biochemical.

Chemical Structure

CAS# 73278-54-3

Theoretical Analysis

MedKoo Cat#: 559062
Name: Lamtidine
CAS#: 73278-54-3
Chemical Formula: C18H28N6O
Exact Mass: 344.2325
Molecular Weight: 344.46
Elemental Analysis: C, 62.76; H, 8.19; N, 24.40; O, 4.64

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: AH-22216; AH22216; AH 22216

IUPAC/Chemical Name: 1-(m-(3-((3-Amino-1-methyl-1H-1,2,4-triazol-5-yl)amino)propoxy)benzyl)piperidine


InChi Code: InChI=1S/C18H28N6O/c1-23-18(21-17(19)22-23)20-9-6-12-25-16-8-5-7-15(13-16)14-24-10-3-2-4-11-24/h5,7-8,13H,2-4,6,9-12,14H2,1H3,(H3,19,20,21,22)


Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 344.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Sorba G, Bertinaria M, Di Stilo A, Gasco A, Scaltrito MM, Brenciaglia MI, Dubini F. Anti-Helicobacter pylori agents endowed with H2-antagonist properties. Bioorg Med Chem Lett. 2001 Feb 12;11(3):403-6. PubMed PMID: 11212121.

2: Coruzzi G, Adami M, Morini G, Pozzoli C, Cena C, Bertinaria M, Gasco A. Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties. J Physiol Paris. 2000 Jan-Feb;94(1):5-10. PubMed PMID: 10761682.

3: Sorba G, Gasco A, Coruzzi G, Adami M, Pozzoli C, Morini G, Bertaccini G. Mixed antisecretory and gastroprotective activities of a new H2-antagonist containing a nitric oxide-donor furoxan moiety. Arzneimittelforschung. 1997 Jul;47(7):849-54. PubMed PMID: 9272244.

4: Le Gros G, Zhang XM, Parsons PG. Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligands. Melanoma Res. 1994 Dec;4(6):359-64. PubMed PMID: 7535606.

5: Schulze FR, Alisch RA, Buschauer A, Schunack W. [Synthesis and combined H1-/H2 antagonist activity of mepyramine, pheniramine and cyclizine derivatives with cyanoguanidine, urea and nitroethenediamine partial structures]. Arch Pharm (Weinheim). 1994 Jul;327(7):455-62. German. PubMed PMID: 7915515.

6: Orsetti M, Sorba G. Characterization of an accessory binding area in the histamine H2 receptor. Eur J Pharmacol. 1991 Jul 12;207(3):259-65. PubMed PMID: 1680063.

7: Büyüktimkin N, Keller F, Schunack W. Gas-liquid chromatographic resolution of some racemic synthons for lamtidine analogous histamine H2-receptor antagonists via diastereomeric amides of (1S)-(-)-camphanic acid. J Chromatogr. 1989 Apr 28;467(2):402-5. PubMed PMID: 2569470.

8: Orsetti M. Histamine H2-receptor blocking activity of ranitidine and lamtidine analogues containing aminomethyl-substituted aliphatic systems. Agents Actions. 1988 Dec;25(3-4):291-5. PubMed PMID: 2905866.

9: Bonjean VJ, Schunack W. [Alkyl- and alkoxy-substituted lamtidine analogs: synthesis and H2-antagonistic activity. 38. H2-antihistaminics]. Arzneimittelforschung. 1988 Apr;38(4):501-7. German. PubMed PMID: 2900010.

10: Orsetti M, Sorba G. Pharmacological profile of new histamine H2-receptor antagonists related to cimetidine, ranitidine and lamtidine. J Pharm Pharmacol. 1988 Jan;40(1):31-4. PubMed PMID: 2896770.

11: Trumm KA, Postius S, Szelenyi I, Schunack W. [Tetrahydroisoquinolines as components of H2-antagonists. 27. H2-antihistaminics]. Arzneimittelforschung. 1986 Aug;36(8):1169-74. German. PubMed PMID: 2877673.

12: Menez I, Gespach C, Emami S, Rosselin G. Irreversible and specific inactivation by AH 22216 of histamine H2 receptors in the human gastric cancer cell line HGT-1. Biochem Biophys Res Commun. 1983 Oct 14;116(1):251-7. PubMed PMID: 6315003.

13: Gespach C, Menez I, Emami S. Potent and specific blockade by AH 22216 of histamine-H2-receptor-mediated acid secretion in isolated rabbit gastric cells. Biosci Rep. 1983 Sep;3(9):871-8. PubMed PMID: 6640083.

14: Stables R, Daly MJ, Humphray JM. Comparison of antisecretory potency and duration of action of the H2-receptor antagonists AH 22216, cimetidine, ranitidine and SK & F 93479 in the dog. Agents Actions. 1983 Apr;13(2-3):166-9. PubMed PMID: 6135321.